The March issue of The Lancet Gastroenterology & Hepatology is out now at https://t.co/bK6A0hWWqa!
Content includes: alcohol & cancer risk, colorectal cancer, inflammatory bowel disease, appendicitis, MASLD, viral hepatitis + more...
#GITwitter#LiverTwitter#MedTwitter
At #ascogi 2025. So excited to listen to the Keynote by @PamelaKunzMD on inclusive medicine and science. Such an apt talk for today's world and changes. 😍
Very proud of @tohhc John Chia Chee Kian and many others (across 11 countries and 66 sites) for bringing this trial to completion after >15 years of hard work and perseverance! A trial started in national cancer centre singapore 🇸🇬 just happy to be part of the story 🥳
Aspirin after completion of standard adjuvant therapy for colorectal cancer (ASCOLT): an international, multicentre, phase 3, randomised, double-blind, placebo-controlled trial - The Lancet Gastroenterology & Hepatology https://t.co/rPSYhiMTfR
Amazing work led by my colleagues!!
New research - Aspirin after completion of standard adjuvant therapy for colorectal cancer (ASCOLT): an international, multicentre, phase 3, randomised, double-blind, placebo-controlled trial
https://t.co/Tg0iWVeNV0
#GITwitter#OncTwitter#MedTwitter@OncoAlert
⚡️Truly an excellent discussion by @LizzySmyth1 @#ESMO23.
💥 KEYNOTE 585 & MATTERHORN - adding immunotherapy as neoadjuvant therapy in locally advanced gastric and GEJ tumors.
🇩🇪 microbiome or the oncologists - why do Germans do FLOT better! 😁
The APGCS 2023 committee members welcome you all to attend the 10th Asia-Pacific Gastroenterology Cancer Summit happening on 18th & 19th August, 2023 in Singapore!
Block Your Calendars and Save the Date!
@Shaheenah1@tohhc@pierce_chow
@sundar__ragha @ShutingHan2@iaintan_mdphd
New Research: The distinct clinical trajectory, metastatic sites, and immunobiology of microsatellite-instability-high cancers: Microsatellite-instability-high (MSI-H) cancers form a spectrum of solid organ tumors collectively known as Lynch… https://t.co/OJTSVFgReq #Genetics
Prof. Toh Han Chong, APGCS Committee and Deputy Director, National Cancer Centre, Singapore, welcoming speech during the 1st day of APGCS 2022!
#apgcs2022
#happeningnow 1st SingHealth Peritoneal Surface Oncology Conference in 🇸🇬!. Congrats to @JohnnyOngCA@Jolenewongsm@ChiaClaramae on the successful opening! #SPRinT Plenarytalk: Prof Med.Beate.Rau on setting up a comprehensive peritoneal centre 💥💥
Delighted to work with @shyam_lab, @SabineTejpar, Joanito & many talented colleagues on our paper, using insights from single-cell & bulk -omics to propose an update to CMS classification of colorectal cancer, in @NatureGenet 1/
https://t.co/kStHkikbCh